Customized Supplier for Closantel sodium injection 5%*100ml,250ml for Latvia Manufacturers

Short Description:


  • Price & Quotation: FOB Shanghai: Discuss in Person
  • Shipment Port: Shanghai, Guangzhou, Chongqing, Yiwu
  • MOQ(5ml,10ml): 30000 Bottles
  • MOQ(50ml,100ml): 5000 Bottles
  • MOQ(250ml,500ml): 2000 Bottles
  • MOQ: Powder/Bolus: 500 KG
  • Payment Terms: T/T, L/C
  • Product Detail

    Send Message

    Related Video

    Feedback (2)

    [rand_pre] [rand_keywords], [rand_keywords], [rand_keywords], [rand_suffix]
    Customized Supplier for Closantel sodium injection 5%*100ml,250ml for Latvia Manufacturers Detail:

    Composition: 
    Each ml contains: Closantel sodium 50mg. 
    Indication: 
    This product is a kind of helminthic. It is active against fasciola hepatica, gastrointestinal eelworms and larvae of arthropods. It is mainly indicated for diseases caused by fasciola hepatica and gastrointestinal eelworms in cattle and sheep, estriasis of sheep and etc.

    Administration and dosage: 
    Subcutaneous or intramuscular injections of a & single; dose of 2.5 to 5mg/kg body weight for cattle and 5 to 10mg/kg body weight for sheep. Adverse reactions:Injections are stimulating to some topical tissues. 
    Precautions: When treating diseases caused by fasciola hepatica it is recommended to repeat the medication after it has been used for 3 weeks to completely eliminate immature fasciola.

    Packing: 100ml, 250ml/bottle. 
    Storage:Tightly sealed and store in a cold place protecting from light. 
    Period of validity: 2 years.

     


    Product detail pictures:

    Customized Supplier for
 Closantel sodium injection 5%*100ml,250ml for Latvia Manufacturers detail pictures


    Related Product Guide:

    [rand_pre] Customized Supplier for Closantel sodium injection 5%*100ml,250ml for Latvia Manufacturers, The product will supply to all over the world, such as: [rand_country], [rand_country], [rand_country], [rand_l_suffix]


  • From PBS and Frontline: “Nightmare bacteria.” That’s how the CDC describes a frightening new threat spreading quickly in hospitals, communities and across the globe. FRONTLINE reporter David Hoffman investigates the alarming rise of untreatable infections: from a young girl thrust onto life support in an Arizona hospital, to a young American infected in India who comes home to Seattle, and an uncontrollable outbreak at the nation’s most prestigious hospital, where 18 patients were mysteriously infected and six died, despite frantic efforts to contain the killer bacteria. Fueled by decades of antibiotic overuse, the crisis has deepened as major drug companies, squeezed by Wall Street expectations, have abandoned the development of new antibiotics. Without swift action, the miracle age of antibiotics could be coming to an end.



    Melinda Neuhauser provides a broad overview and national perspective on antibiotic use in inpatient settings, unintended consequences of antibiotic use, and antibiotic stewardship programs during the 2017 NHSN Training.

    Comments on this video are allowed in accordance with our comment policy:

    https://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html

    This video can also be viewed at

    [rand_feedback]
    5 Stars By [rand_feedback_name] from [rand_country] - [rand_feedback_time]
    [rand_feedback]
    5 Stars By [rand_feedback_name] from [rand_country] - [rand_feedback_time]